13F-HR filed by Avoro Capital Advisors LLC
Avoro Capital Advisors LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 11:49:53 UTC, with 30 holding rows worth $9,690,900,114.
- Accession
- 0001104659-26-127608
- Filer
- CIK 1633313
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 30 entries on the cover page, a total value of $9,690,900,114 stated on the cover page (in dollars after the unit check, H1), rows summing to $9,690,900,114 with VALUE read as dollars as filed, 13F file number 028-16573. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 2,755,555 | $1,493,207,699 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 5,050,000 | $1,150,541,500 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 2,888,888 | $960,728,593 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 1,000,000 | $958,910,000 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 1,833,333 | $923,926,499 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 7,474,747 | $835,601,967 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 11,000,000 | $719,950,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 2,145,000 | $440,282,700 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 4,900,000 | $322,959,000 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 7,050,000 | $268,323,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 6,555,555 | $204,992,205 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 5,500,000 | $204,545,000 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 5,635,000 | $181,954,150 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 6,727,777 | $162,543,092 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 1,500,000 | $119,280,000 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 23,888,888 | $116,338,885 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 12,380,300 | $94,956,901 | dollars as filed | |
| DAMORA THERAPEUTICS INC | G2646Y104 | COMM STK | 3,783,000 | $80,502,240 | dollars as filed | |
| HEMAB THERAPEUTICS HLDGS INC | 423494103 | COM SHS | 1,892,372 | $58,360,752 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,500,000 | $51,475,000 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 1,300,000 | $50,869,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 488,000 | $48,321,760 | dollars as filed | |
| SCRIBE THERAPEUTIC COM | 811033109 | COM | 2,598,973 | $47,834,098 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 1,410,000 | $41,933,400 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 1,770,000 | $41,559,600 | dollars as filed | |
| Biohaven Pharmaceutical Holding Co. Ltd | G111OE107 | Common | 2,750,000 | $36,712,500 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 2,377,777 | $36,451,321 | dollars as filed | |
| Braveheart Bio Inc | 10567X101 | COM | 1,255,000 | $25,351,000 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 2,849,402 | $10,713,752 | dollars as filed | |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 525,000 | $1,774,500 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-127608 | this filing | 2026-11-16 |